XML 25 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP Shares [Member]
Dow Inc. [Member]
Retained Earnings [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock [Member]
The Dow Chemical Company
Additional Paid-in Capital [Member]
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP Shares [Member]
The Dow Chemical Company
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2019   $ 8 $ 7,325 $ 17,045 $ (10,246) $ (91)     $ 0 $ 7,333 $ 17,313 $ (10,246) $ (91)  
Stock Issued                   30        
Stock-based compensation and allocation of ESOP shares     76     22       76     22  
Net income available for The Dow Chemical Company common stockholder $ 10     14             14      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (1,172)              
Other       8             (8)      
Other comprehensive income 21       21     $ 21       21    
Total Equity, Ending at Jun. 30, 2020 13,097 8 7,431 16,017 (10,225) (69)   13,852 0 7,439 16,147 (10,225) (69) $ 560
Total Equity, Beginning at Mar. 31, 2020   8 7,370 16,763 (10,529) (81)     0 7,378 16,905 (10,529) (81)  
Stock Issued                   14        
Stock-based compensation and allocation of ESOP shares     47     12       47     12  
Net income available for The Dow Chemical Company common stockholder (227)     (225)             (225)      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (529)              
Other       5             (4)      
Other comprehensive income 304       304     304       304    
Total Equity, Ending at Jun. 30, 2020 13,097 8 7,431 16,017 (10,225) (69)   13,852 0 7,439 16,147 (10,225) (69) 560
The Dow Chemical Company’s stockholders’ equity 12,537             13,292            
The Dow Chemical Company’s stockholders’ equity 12,435             12,999            
Total Equity, Beginning at Dec. 31, 2020 13,005 8 7,595 16,361 (10,855) (49)   13,569 0 7,603 16,300 (10,855) (49)  
Stock Issued                   200        
Stock-based compensation and allocation of ESOP shares     103     17       103     17  
Net income available for The Dow Chemical Company common stockholder 2,877     2,892             2,897      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             (1,442)              
Other       10             (10)      
Other comprehensive income 1,179       1,179     1,179       1,179    
Total Equity, Ending at Jun. 30, 2021 16,153 8 7,898 18,200 (9,676) (32)   16,523 0 7,906 17,745 (9,676) (32) 580
Total Equity, Beginning at Mar. 31, 2021   8 7,743 16,829 (9,913) (39)     0 7,751 16,577 (9,913) (39)  
Stock Issued                   73        
Stock-based compensation and allocation of ESOP shares     82     7       82     7  
Net income available for The Dow Chemical Company common stockholder 1,891     1,901             1,914      
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (739)              
Other       8             (7)      
Other comprehensive income 237       237     237       237    
Total Equity, Ending at Jun. 30, 2021 16,153 $ 8 $ 7,898 $ 18,200 $ (9,676) $ (32)   16,523 $ 0 $ 7,906 $ 17,745 $ (9,676) $ (32) $ 580
The Dow Chemical Company’s stockholders’ equity $ 15,573             $ 15,943